Accutest Research Laboratory (ARL) and Fox Chase Cancer Center formed a partnership under which Accutest will assist with expanding the Fox Chase clinical research footprint abroad. ARL is a leading global independent and internationally accredited CRO, offering the highest quality standards and has a strong regulatory track record. ARL has capabilities to execute Phase II to IV clinical trials in Asia and Latin America.
About Our Partnership
Memorandum of Understanding.
Potential clinical trial collaborations in Asia and Latin America.
